Avantax Advisory Services, Inc. Ptc Therapeutics, Inc. Transaction History
Avantax Advisory Services, Inc.
- $14.9 Billion
- Q3 2024
A detailed history of Avantax Advisory Services, Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 9,104 shares of PTCT stock, worth $420,968. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,104
Previous 9,088
0.18%
Holding current value
$420,968
Previous $277,000
21.66%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PTCT
# of Institutions
221Shares Held
78.1MCall Options Held
144KPut Options Held
58.7K-
Vanguard Group Inc Valley Forge, PA9.13MShares$422 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$365 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$359 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$342 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$335 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.31B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...